durvalumab 50 MG/ML
RxNorm concept 1919504, clinical drug component (scdc).
- RxCUI
- 1919504
- Term type
- Clinical drug component (SCDC)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1919504 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- 2.4 ML durvalumab 50 MG/ML Injection (SCD, constitutes)
- 2.4 ML durvalumab 50 MG/ML Injection [Imfinzi] (SBD, constitutes)
- 10 ML durvalumab 50 MG/ML Injection (SCD, constitutes)
- 10 ML durvalumab 50 MG/ML Injection [Imfinzi] (SBD, constitutes)
- durvalumab (IN, has ingredient)
- durvalumab 50 MG/ML [Imfinzi] (SBDC, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1919504 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1919504 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1919504. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.